Skip to content

Analgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain

Analgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain by Active and Latent Myofascial Trigger Points.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03869710
Enrollment
0
Registered
2019-03-11
Start date
2019-03-08
Completion date
2023-12-25
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head Pain, Neck Pain

Keywords

Pain

Brief summary

The analgesic effects of ultrasound-guided dry-needling therapy will be evaluated in the management of head and neck pain.

Detailed description

The analgesic effects of ultrasound-guided dry-needling therapy will be evaluated in the management of head and neck pain by myofascial active and latent trigger point. The myofascial pain control will be assessed for the superficial and deep posterolateral muscle complex of neck. The analgesic request, Range Of Motion (ROM), Motion Related Pain (MRP) and the quality of life, will be also assessed.

Interventions

DEVICEUltrasound-guided Dry-Needling Therapy

The needle will be insert under ultrasound guidance to elicit the myofascial response on the neck of the patients

Sponsors

San Salvatore Hospital of L'Aquila
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Chronic neck pain * Chronic head pain

Exclusion criteria

* previous surgery of neck and head * Body Mass Index \> 39,99 * politrauma patients * pregnancy * neck and head infections

Design outcomes

Primary

MeasureTime frameDescription
Trigger PointThe first hour of the treatmentThe number of the elicited myofascial trigger points assessed during dry-needling treatment

Secondary

MeasureTime frameDescription
Analgesic request3 months trom treatmentThe analgesic request will be assessed in mg of equianalgesic morphine
Karnofsky Performance Status3 months from treatmentThe quality of life assessed by Karnofsky Performance Status (a 0-100 steps scale, from 0 \[Dead\] to 100 \[Normal no complaints; no evidence of disease\]).
Range Of Motion (ROM)3 months after treatmentThe alpha angle expressed in degrees and assessed during
Motion Related Pain3 months after treatmentPain assessed by Numeric Rating Scale (a 10-steps scale, from 0 \[no pain\] to 10 \[worse pain\]), during flexion, extension and rotation of neck and head
Perception3 months after treatmentPain assessed by Numeric Rating Scale (a 10-steps scale, from 0 \[no pain\] to 10 \[worse pain\])

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026